£830K
The funding round was led by Chris Torrance and backed by the Angel CoFund alongside a crowd of angel investors.
"We are extremely excited to team up with a fantastic set of investors, enabling us to take this project further over the next two years. Depression remains severely undertreated, and with these funds in place we can move forward with a focus on developing our drug candidate to help address the unmet needs of patients with depression."
